Latest News

Daily Dose: "Night Owls" Less Healthy, at Higher Risk for T2D / image credit folders-stethoscope  ©New Africa/AdobeStock
Daily Dose: Long-COVID Rehabilitation Interventions

September 28th 2023

Your daily dose of the clinical news you may have missed.

Daily Dose: "Night Owls" Less Healthy, at Higher Risk for T2D / image credit folders-stethoscope  ©New Africa/AdobeStock
Daily Dose: Dupilumab Potent Against Uncontrolled COPD with Type 2 Inflammation

September 26th 2023

Long COVID Rehab Interventions Improve but Safety Research still needed image credit ©Nejron Photo/stock.adobe.com
Long-COVID Rehabilitation Interventions Improve Symptoms but Research on Safety Still Needed

September 21st 2023

Dupilumab Potent Against Uncontrolled COPD with T2 Inflammation: BOREAS Trial Update image credit man coughing digitalskillet1/stock.adobe.com
Dupilumab Potent Against Uncontrolled COPD with T2 Inflammation: BOREAS Trial Update

September 15th 2023

Remdesivir Gets FDA “OK” for COVID-19 Treatment in Hepatic Disease Across Stages  image credit remdesivir ©Bernard Chantal/stock.adobe.com
Remdesivir Gets FDA “OK” for COVID-19 Treatment in Hepatic Disease Across Stages

August 25th 2023

Video Interviews
Podcasts
Latest CME Events & Activities

Community Practice Connections™: Chronic Fibrosing ILDs With Progressive Phenotype–Are You Aware of the Latest Data on Diagnosis and Emerging Treatments?

View More

Catching Them Early: A Real-World Case Discussion on the Application of Testing Methodologies to Identify Key Markers Across NSCLC

View More

2022 BURST Year in Review™: How Has Recent Evidence in Testing Elevated Outcomes in Patients with Lung Cancers

View More

Community Practice Connections™: 23rd Annual International Lung Cancer Congress®

View More

41st Annual CFS®: Innovative Cancer Therapy for Tomorrow®

Register Now!

18th Annual New York Lung Cancers Symposium®

Register Now!

2023 Respiratory Summit

View More

Virtual Testing Board: Digging Deeper on Your Testing Reports to Elevate Patient Outcomes in Advanced Non–Small Cell Lung Cancer

View More

Medical Crossfire: How Should We Leverage Multidisciplinary Lung Cancer Care Teams in Managing Earlier Forms of NSCLC... When the Goal Is Cure?

View More

Advancing Precision Care Through Biomarker-Driven Therapy: CEACAM5 as a Therapeutic Target in NSCLC

View More

Addressing Healthcare Inequities: Overcoming Challenges in the Equitable Management of Idiopathic Pulmonary Fibrosis

View More

Community Practice Connections™: Pathology Oncology Collaborative: Biomarker Testing in an Emerging Era of HER2 Across Breast, GI, and Lung Cancers

View More

How CEACAM5 Expression Can Be Measured and Leveraged in NSCLC Care: Current Developments & Future Therapeutic Opportunities

Register Now!

Burst CME™ - Part III – Advent of HER3 Targeted Approaches and Rationale in Breast Cancer Care

View More

Burst CME™ - Part I – Overview of Pathophysiology, Diagnosis, and Management of HER3 Expressing Cancers

View More

Burst CME™ - Part II – Advent of HER3 Targeted Approaches and Rationale in NSCLC Care

View More

Show Me Your Care Plan™: Monitoring and Managing Patients With EGFR Exon20 Insertion+ NSCLC

View More

Addressing Healthcare Inequities: Tailoring Management Plans to Address Healthcare Disparities in Cystic Fibrosis

View More

Medical Crossfire®: Antibody-Drug Conjugates Coming to Your Oncology Practice Tomorrow

View More

2nd Annual Hawaii Lung: A Multidisciplinary Case-Based Conference™

Register Now!

Community Practice Connections™: 17th Annual New York Lung Cancers Symposium

View More

Addressing Healthcare Inequities™: Tailoring Management Plans to Address Healthcare Disparities in Cystic Fibrosis

View More

Navigating the Latest Data on NTRK-Targeted Therapies

View More

Trekking Through the Latest Updates for ROS1-Targeted Therapies

View More

Community Practice Connections™: 6th Annual Precision Medicine Through Plasma™ – Using Liquid Biopsies in Contemporary Oncology Care

View More

Clinical Vignettes: 40th Annual CFS®: Innovative Cancer Therapy for Tomorrow®

View More

Mapping Out the Role of Emerging Biomarkers and Testing in NSCLC

View More

21st Annual Winter Lung Cancer Conference®

Register Now!

Community Practice Connections™: Guidebook for Community Oncology NSCLC Treating Teams to Administer EGFR Exon 20-Targeted Regimens

View More

Community Practice Connections™: 1st Annual Hawaii Lung: A Multidisciplinary Case-Based Conference™

View More

More News

© 2023 MJH Life Sciences

All rights reserved.